Medtech developing fluorescence-based tissue detection systems for tumour surgery.
| Date | Round | Amount |
|---|---|---|
| Aug 2025 | Seed Marginum raised €2.5 million in a pre-Series A round led by Nostetta Ventures for its fluorescence-based tumor detection technology. | $2.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.